RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Proceeds from issuance of term debt, net

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndProceeds from issuance of term debt, net (Million USD)YoY (%)
Jun 30, 2024105-90.19%
Jun 30, 20231,070+271.53%
Jun 30, 2022288+220.00%
Jun 30, 202190-92.44%
Jun 30, 20201,190-21.67%
Jun 30, 20191,519+334.07%
Jun 30, 2018350-22.22%
Jun 30, 2017450-60.53%
Jun 30, 20161,140+533.33%
Jun 30, 2015180-67.73%
Jun 30, 2014558+271.89%
Jun 30, 2013150-44.52%
Jun 30, 2012270+174.70%
Jun 30, 201198

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)